Vitrolife AB (VITR) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Vitrolife AB (VITR) has a cash flow conversion efficiency ratio of 0.017x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr140.00 Million ≈ $15.07 Million USD) by net assets (Skr8.13 Billion ≈ $875.35 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Vitrolife AB (VITR) total market value for the company's overall valuation and market capitalisation.
Vitrolife AB - Cash Flow Conversion Efficiency Trend (2002–2025)
This chart illustrates how Vitrolife AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Vitrolife AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Vitrolife AB ranked by their cash flow conversion efficiency. Explore VITR cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
National Vision Holdings Inc
NASDAQ:EYE
|
0.009x |
|
Dalian Bio-Chem Co Ltd
SHG:603360
|
0.098x |
|
Innuovo Technology Co Ltd Class A
SHE:000795
|
0.050x |
|
Norwegian Air Shuttle ASA
OL:NAS
|
1.090x |
|
Globant S.A.
LSE:0RIX
|
N/A |
|
Sino Prima Gas Technology Co Ltd
SHE:300483
|
0.136x |
|
MPC Container Ships ASA
OL:MPCC
|
0.080x |
|
Telling Telecommunication Holding Co Ltd
SHE:000829
|
-0.229x |
Annual Cash Flow Conversion Efficiency for Vitrolife AB (2002–2025)
The table below shows the annual cash flow conversion efficiency of Vitrolife AB from 2002 to 2025. View VITR stock price and chart for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr7.89 Billion ≈ $849.63 Million |
Skr635.00 Million ≈ $68.34 Million |
0.080x | +20.97% |
| 2024-12-31 | Skr13.64 Billion ≈ $1.47 Billion |
Skr907.00 Million ≈ $97.61 Million |
0.066x | +11.75% |
| 2023-12-31 | Skr12.72 Billion ≈ $1.37 Billion |
Skr757.00 Million ≈ $81.47 Million |
0.059x | +56.60% |
| 2022-12-31 | Skr16.74 Billion ≈ $1.80 Billion |
Skr636.00 Million ≈ $68.44 Million |
0.038x | +51.66% |
| 2021-12-31 | Skr15.34 Billion ≈ $1.65 Billion |
Skr384.31 Million ≈ $41.36 Million |
0.025x | -85.82% |
| 2020-12-31 | Skr2.02 Billion ≈ $217.06 Million |
Skr356.45 Million ≈ $38.36 Million |
0.177x | -23.14% |
| 2019-12-31 | Skr1.80 Billion ≈ $193.45 Million |
Skr413.33 Million ≈ $44.48 Million |
0.230x | -1.55% |
| 2018-12-31 | Skr1.50 Billion ≈ $161.02 Million |
Skr349.44 Million ≈ $37.60 Million |
0.234x | -8.09% |
| 2017-12-31 | Skr1.23 Billion ≈ $132.22 Million |
Skr312.19 Million ≈ $33.60 Million |
0.254x | +43.04% |
| 2016-12-31 | Skr1.02 Billion ≈ $109.81 Million |
Skr181.26 Million ≈ $19.51 Million |
0.178x | -22.44% |
| 2015-12-31 | Skr844.97 Million ≈ $90.93 Million |
Skr193.53 Million ≈ $20.83 Million |
0.229x | +10.47% |
| 2014-12-31 | Skr702.57 Million ≈ $75.61 Million |
Skr145.67 Million ≈ $15.68 Million |
0.207x | -36.98% |
| 2013-12-31 | Skr322.60 Million ≈ $34.72 Million |
Skr106.13 Million ≈ $11.42 Million |
0.329x | +53.14% |
| 2012-12-31 | Skr278.98 Million ≈ $30.02 Million |
Skr59.93 Million ≈ $6.45 Million |
0.215x | +87.22% |
| 2011-12-31 | Skr343.90 Million ≈ $37.01 Million |
Skr39.46 Million ≈ $4.25 Million |
0.115x | -22.63% |
| 2010-12-31 | Skr326.33 Million ≈ $35.12 Million |
Skr48.40 Million ≈ $5.21 Million |
0.148x | +11.59% |
| 2009-12-31 | Skr312.07 Million ≈ $33.58 Million |
Skr41.48 Million ≈ $4.46 Million |
0.133x | -9.19% |
| 2008-12-31 | Skr292.39 Million ≈ $31.47 Million |
Skr42.79 Million ≈ $4.61 Million |
0.146x | +74.23% |
| 2007-12-31 | Skr253.38 Million ≈ $27.27 Million |
Skr21.29 Million ≈ $2.29 Million |
0.084x | -22.07% |
| 2006-12-31 | Skr220.64 Million ≈ $23.74 Million |
Skr23.78 Million ≈ $2.56 Million |
0.108x | +34.70% |
| 2005-12-31 | Skr176.45 Million ≈ $18.99 Million |
Skr14.12 Million ≈ $1.52 Million |
0.080x | -13.96% |
| 2004-12-31 | Skr150.57 Million ≈ $16.20 Million |
Skr14.01 Million ≈ $1.51 Million |
0.093x | -57.25% |
| 2003-12-31 | Skr143.44 Million ≈ $15.44 Million |
Skr31.20 Million ≈ $3.36 Million |
0.218x | -30.30% |
| 2002-12-31 | Skr111.40 Million ≈ $11.99 Million |
Skr34.77 Million ≈ $3.74 Million |
0.312x | -- |
About Vitrolife AB
Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. The company also provides eWitness and Labware … Read more